Affinity Asset Advisors »

iShares NASDAQ Biotechnology Index shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $68M 400k 168.77

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding iShares NASDAQ Biotechnology Index

Bnp Paribas Arbitrage, Snc
Envestnet Asset Management
Goldman Sachs Group
Susquehanna International
Jpmorgan Chase & Co
LPL Financial
UBS Group
Commerce Bank N A
Wells Fargo & Company
Barclays
Branch Banking & Trust Company
WestEnd Advisors
Janney Montgomery Scott
Healthcare Of Ontario Pension Plan Trust Fund
Calamos Advisors

View all funds holding iShares NASDAQ Biotechnology Index